Does metformin affect ovarian morphology in patients with polycystic ovary syndrome? A retrospective cross-sectional preliminary analysis

Journal of Ovarian Research

Volumn 2, Issue 1, 2009, Pages

  Falbo, Angela ^a   Orio, Francesco ^b   Venturella, Roberta ^a   Rania, Erika ^a   Materazzo, Caterina ^a   Tolino, Achille ^c   Zullo, Fulvio ^a   Palomba, Stefano ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; METFORMIN; TESTOSTERONE;

ADULT; ANOVULATION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MORPHOLOGY; OVARY; OVARY POLYCYSTIC DISEASE; OVULATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION;

EID: 77952323191     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-2-5     Document Type: Article

References (28)

1. Amenorrhea associated with bilateral polycystic ovaries. IF Stein ML Leventhal, Am J Obstet Gynecol 1935 29 181 191
2. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. J Adams DW Polson S Franks, Br Med J (Clin Res Ed). 1986 293 6543 355 359 10.1136/bmj.293.6543.355 3089520
3. Standards for ovarian volume in childhood and puberty. NA Bridges A Cooke MJ Healy PC Hindmarsh CG Brook, Fertil Steril 1993 60 456 460 8375526
4. Polycystic ovaries in childhood: a common finding in daughters of PCOS patients. A pilot study. C Battaglia G Regnani F Mancini L Iughetti C Flamigni S Venturoli, Hum Reprod 2002 17 771 776 10.1093/humrep/17.3.771 11870134
5. Polycystic ovaries in pre and postmenopausal women. MA Birdsall CM Farquhar, Clin Endocrinol (Oxf) 1996 44 269 276 10.1046/j.1365-2265.1996.676498. x 8729521
6. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. E Dahlgren S Johansson G Lindstedt F Knutsson A Oden PO Janson LA Mattson N Crona PA Lundberg, Fertil Steril 1992 57 505 513 1740195
7. Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth. L Ib̃ez A Lápez-Bermejo J Callejo A Torres S Cabré D Dunger F de Zegher, J Clin Endocrinol Metab 2008 93 196 199 10.1210/jc.2007-1800 17956949
8. Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. RJ Norman WM Hague SC Masters XJ Wang, Hum Reprod 1995 10 2258 2261 8530647
9. Polycystic ovaries in hirsute women with normal menses. E Carmina RA Lobo, Am J Med 2001 111 602 606 10.1016/S0002-9343(01)00979-2 11755502
10. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound. E Carmina L Wong L Chang RJ Paulson MV Sauer FZ Stanczyk RA Lobo, Hum Reprod 1997 12 905 909 10.1093/humrep/12.5.905 9194637
11. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. C Gilling-Smith H Story V Rogers S Franks, Clin Endocrinol (Oxf) 1997 47 93 99 10.1046/j.1365-2265.1997.2321049.x 9302378
12. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropinreleasing hormone-agonist testing. PL Chang SR Lindheim C Lowre M Ferin F Gonzalez L Berglund E Carmina MV Sauer RA Lobo, J Clin Endocrinol Metab 2000 85 995 1000 10.1210/jc.85.3.995 10720029
13. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters. E Carmina F Orio S Palomba RA Longo G Lombardi RA Lobo, Fertil Steril 2005 84 413 419 10.1016/j.fertnstert. 2004.12.061 16084883
14. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. A Dunaif, Endocr Rev 1997 18 774 800 10.1210/er.18.6.774 9408743
15. Metformin. CJ Bailey RC Turner, N Engl J Med 1996 334 574 579 10.1056/NEJM199602293340906 8569826
16. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. S Palomba A Falbo F Zullo F Orio Jr, Endocr Rev 2009 30 1 50 10.1210/er.2008-0030 19056992
17. Effects of metformin and clomiphene citrate on ovarian vascularity in patients with polycystic ovary syndrome. S Palomba F Orio Jr A Falbo T Russo A Tolino F Zullo, Fertil Steril 2006 86 1694 1701 10.1016/j.fertnstert.2006.05.035 17074337
18. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. JK Zawadzki A Dunaif, Polycystic ovary syndrome Boston: Blackwell, Dunaif A, Givens JR, Haseltine FP, Merriam GR, 1992 337 384
19. Ultrasound assessment of the polycystic ovary: international consensus definitions. AH Balen JS Laven SL Tan D Dewailly, Hum Reprod Update 2003 9 505 514 10.1093/humupd/dmg044 14714587
20. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. PH Ducluzeau P Cousin E Malvoisin H Bornet H Vidal M Laville M Pugeat, J Clin Endocrinol Metab 2003 88 3626 3631 10.1210/jc.2003-030219 12915646
21. Clinical assessment of body hair growth in women. D Ferriman JD Gallwey, J Clin Endocrinol Metab 1996 121 1440 1447
22. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology. A Bayrak H Terbell R Urwitz-Lane E Mor FZ Stanczyk RJ Paulson, Fertil Steril 2007 87 870 875 10.1016/j.fertnstert.2006.08. 096 17224152
23. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. JM Adams AE Taylor WF Crowley Jr JE Hall, J Clin Endocrinol Metab 2004 89 4343 4350 10.1210/jc.2003-031600 15356031
24. Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome. MK Murphy JE Hall JM Adams H Lee CK Welt, J Clin Endocrinol Metab 2006 91 3878 3884 10.1210/jc.2006-1085 16882750
25. Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome. S Palomba A Falbo T Russo F Manguso A Tolino F Zullo P De Feo F Orio Jr, J Clin Endocrinol Metab 2007 92 3128 3135 10.1210/jc.2007-0441 17519312
26. Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome. S Palomba A Falbo F Orio Jr A Tolino F Zullo, Fertil Steril. 2009 91 6 2557 2567 10.1016/j.fertnstert.2008.03.011 18440534
27. Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. D Romualdi M Giuliani F Cristello AM Fulghesu L Selvaggi A Lanzone M Guido, Fertil Steril 2009 19268929
28. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. T Piltonen L Morin-Papunen R Koivunen A Perheentupa A Ruokonen JS Tapanainen, Hum Reprod 2005 20 1820 6 10.1093/humrep/deh850 15802325